title: Revolutionizing treatment outcomes in hepatitis C: managed care implications and considerations--diagnosis and management.
abstract: Hepatitis C virus (HCV) infection is a major health burden and associated with substantial morbidity and mortality. However, the disease often remains underdiagnosed and untreated. The treatment of HCV infection has evolved dramatically with the introduction of novel, interferon-free therapies that are now able to achieve high cure rates. However, improved and more effective strategies for controlling the high costs of managing patients with HCV, especially in light of the shifting treatment paradigm, need to be developed. This article, the second in a series of 3 focused on hepatitis C, will discuss the diagnosis and management of HCV infection, including treatment recommendations from practice guidelines and emerging agents to treat HCV, and provide suggestions for incorporating these options into treatment algorithms.
authors.affiliation: monicashah23@gmail.com.
authors.forename: Monica
authors.initials: M
authors.lastname: Shah
authors.forename: Zobair M
authors.initials: ZM
authors.lastname: Younossi
mesh_terms: D000998:Antiviral Agents / Q000627:therapeutic use*; D002986:Clinical Trials as Topic; D005838:Genotype; D016174:Hepacivirus / Q000235:genetics; D019698:Hepatitis C, Chronic / Q000175:diagnosis* / Q000188:drug therapy*; D006801:Humans; D008329:Managed Care Programs; D017410:Practice Guidelines as Topic
chemical_list: D000998:Antiviral Agents